Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.62 |
| ▸ | HSPB1 | P04792 | 4/20 | 0.50 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | HTT | P42858 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29462663 | 1.00 | ATM (0.69) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| Hydrogen Sulfide SCHEMBL21810723 | 0.98 | ATM (0.67) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| SCHEMBL216553 | 0.84 | TDP1 (0.72) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| SCHEMBL29745239 | 0.84 | TDP1 (0.72) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| SCHEMBL6314467 | 0.84 | ALDH1A1 (0.58) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| SCHEMBL18302787 | 0.83 | TDP1 (0.55) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| SCHEMBL29385912 | 0.82 | TDP1 (1.00) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| SCHEMBL29462665 | 0.82 | ATM (0.63) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| SCHEMBL57112 | 0.82 | TDP1 (1.00) | ATMTDP1ALDH1A1HIF1AVCAM1 | |
| SCHEMBL11579276 | 0.82 | ALDH1A1 (0.67) | ATMTDP1ALDH1A1HIF1AVCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117427680-A | Preparation method of aromatic amine and unsaturated quinoline derivative | 烟台先进材料与绿色制造山东省实验室 | 2024-01-23 | — | — | CN | claimed |
| CN-115772083-A | Method for synthesizing 2, 5-difluoronitrobenzene by using vortex continuous flow reactor | 南通海晴医药科技有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-114292298-A | Preparation method of integrated phosphine-light-emitting carbazolyl organic photoelectric material | 安阳工学院 | 2022-04-08 | — | — | CN | claimed |
| CN-109553534-A | A kind of preparation method of 2- nitro -4- methoxy benzoic acid | 常州大学 | 2019-04-02 | — | — | CN | claimed |
| CN-107376875-A | A kind of preparation and application of the beta cyclodextrin porous material with quick adsorption ability | 湖南理工学院 | 2017-11-24 | — | — | CN | claimed |
| US-9169200-B2 | Polymer supported reagents and methods or reducing aromatic nitro compounds by using the same | LG CHEM, LTD. (KR) | 2015-10-27 | — | — | US | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| US-20130253083-A1 | POLYMER SUPPORTED REAGENTS AND METHODS OR REDUCING AROMATIC NITRO COMPOUNDS BY USING THE SAME | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) | 2013-09-26 | — | — | US | claimed |
| WO-2012128515-A9 | POLYMER SUPPORTED REAGENTS AND METHODS OF REDUCING AROMATIC NITRO COMPOUNDS BY USING THE SAME | LG CHEM, LTD. (KR) | 2012-12-20 | — | — | WO | claimed |
| WO-2012128515-A2 | POLYMER SUPPORTED REAGENTS AND METHODS OF REDUCING AROMATIC NITRO COMPOUNDS BY USING THE SAME | LG CHEM, LTD. (KR) | 2012-09-27 | — | — | WO | claimed |
| WO-2008008273-A1 | POLYMORPHIC FORM OF FLUORO-7-(2,2,2-TRIFLUOROETHOXY) PHENOXATHIIN-10,10-DIOXIDE | CENERX BIOPHARMA, INC. (US) | 2008-01-17 | — | — | WO | claimed |
| WO-2007083090-A2 | PROCESS FOR THE PREPARATION OF URACIL DERIVATIVES | SYNGENTA LIMITED (GB) | 2007-07-26 | — | — | WO | claimed |
| JP-60013743-A | — | — | None | — | — | JP | disclosed |
| JP-5201957-A | — | — | None | — | — | JP | disclosed |
| EP-3233077-B1 | DOPAMINE D2 RECEPTOR LIGANDS | BROAD INST INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12616682-B2 | 1-H-pyrrolo[2,3-c]pyridine compounds | ACERTA PHARMA B.V. (NL) | 2026-05-05 | — | — | US | disclosed |
| US-4115574-A | CNS ACTIVITY | LILLY INDUSTRIES LIMITED (GB) | 1978-09-19 | — | — | US | disclosed |
| US-4089958-A | HYPOTENSIVE AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-05-16 | — | — | US | disclosed |
| US-4032639-A | 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-06-28 | — | — | US | disclosed |
| US-3953510-A | Method for the preparation of alkoxyanilines | OLIN CORPORATION (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130253083-A1 | POLYMER SUPPORTED REAGENTS AND METHODS OR REDUCING AROMATIC NITRO COMPOUNDS BY USING THE SAME | NOS2, PPOX, NOS1 | ATM 327/4885TDP1 2333/4885ALDH1A1 2495/4885 |
| US-12616682-B2 | 1-H-pyrrolo[2,3-c]pyridine compounds | MEN1, PKD1, PKD2 | ATM 3736/4885TDP1 2754/4885ALDH1A1 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.